PFE
PFE clinical trials: PFIZER INC
Every trial on ClinicalTrials.gov where PFIZER INC is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 5,935
- Trials linked
- 4,040
- As lead sponsor
- 1,895
- As collaborator
- 29
- Primary completions as lead sponsor, next 90 days
PFE on the catalyst calendar · PFE registry changes
- Primary completion Oct 24, 2026ActualNo phase registeredNCT06898047Consistency of Response With Rimegepant in Acute Treatment of MigrainePfizer · MigraineCompletedPFELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 2, 2029Sponsor estimatePhase 3NCT06760637Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment...Pfizer · Breast CancerActive, not recruitingPFELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 1, 2027Sponsor estimateNo phase registeredNCT07897669A Real-world Study to Learn About of the Characteristics and Outcomes of Advanced or Metastatic Bladder Cancer Patients With Different...Pfizer · Metastatic Urothelial CarcinomaActive, not recruitingPFELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 19, 2028Sponsor estimatePhase 3NCT06873945A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia AreataPfizer · Alopecia AreataRecruitingPFELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 28, 2028Sponsor estimateNo phase registeredNCT06651073ATTR-CM: A Multi-country, Non-interventional Disease RegistryPfizer · Transthyretin Amyloid CardiopathyActive, not recruitingPFELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 19, 2031Sponsor estimatePhase 1/Phase 2NCT05805826To Understand the Safety and Effects of a C. Difficile Vaccine With New Adds-Ons That Will Be Given to Healthy AdultsPfizer · Clostridoides Difficile Associated DiseaseActive, not recruitingPFELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 13, 2028Sponsor estimatePhase 3NCT07932925A Study to Learn About the Safety and Effectiveness of Berobenatide in Women With Urine Leakage and With Obesity or Overweight (VESPER-SUI)Pfizer · Urinary Incontinence, StressRecruitingPFELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 5, 2029Sponsor estimatePhase 3NCT07629440A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.Pfizer · Pneumococcal DiseaseRecruitingPFELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 26, 2030Sponsor estimatePhase 3NCT07029828A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.Pfizer · Severe Alopecia AreataRecruitingPFELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 5, 2027Sponsor estimatePhase 1NCT06703606A Study to Learn About How Changing Therapy From Emicizumab to Marstacimab Affects People With the Severe Hemophilia A.Pfizer · Severe Hemophilia ARecruitingPFELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 31, 2025ActualPhase 3NCT05654623A Study to Learn About a New Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People Who Have Advanced Metastatic Breast CancerPfizer · Advanced Breast CancerActive, not recruitingPFELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 10, 2028Sponsor estimatePhase 3NCT05611801A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia BPfizer · Hemophilia ARecruitingPFELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 25, 2040Sponsor estimatePhase 3NCT05568719Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B RespectivelyPfizer · Hemophilia ARecruitingPFELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 20, 2026ActualNo phase registeredNCT04876781Korean Post-marketing Surveillance for Xeljanz XRPfizer · Active Moderate to Severe Rheumatoid ArthritisCompletedPFELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2, 2024ActualPhase 3NCT04165317A Study of Sasanlimab in People With Non-muscle Invasive Bladder CancerPfizer · Non-muscle Invasive Bladder CancerActive, not recruitingPFELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 26, 2031Sponsor estimatePhase 1NCT07903415A Study to Learn About the Study Medicine Called PF-08098488 in People With Advanced Solid Tumors.Pfizer · Pancreatic Ductal AdenocarcinomaRecruitingPFELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 22, 2030Sponsor estimatePhase 1NCT07897721A Study to Learn About the Study Medicine Called PF-08165784 in People With PIK3CA-Mutated Advanced or Metastatic Solid TumorsPfizer · Advanced Breast CancerNot yet recruitingPFELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 30, 2028Sponsor estimateNo phase registeredNCT07859527A Study to Learn About the Study Medicine (Called Marstacimab) in People With Hemophilia A or BPfizer · HemophiliaRecruitingPFELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 21, 2034Sponsor estimatePhase 3NCT07839884A Continuation Study of Tilrekimig in Adults With Moderate-to-Severe Long-Term Breathing Difficulty, Known by the Medical Term of...Pfizer · Moderate to Severe Chronic Obstructive Pulmonary DiseaseRecruitingPFELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 1, 2027Sponsor estimateNo phase registeredNCT07567352A Study to Learn About Patients With Non-Small Cell Lung Cancer (NSCLC) Who Took Lorlatinib as Their First TreatmentPfizer · Non-Small-Cell LungActive, not recruitingPFELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 14, 2030Sponsor estimatePhase 2/Phase 3NCT07226999Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy and With Tarlatamab...Pfizer · Small Cell Lung Cancer (SCLC)RecruitingPFELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 30, 2027Sponsor estimatePhase 3NCT06629779A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.Pfizer · Metastatic Castration-Resistant Prostate CancerActive, not recruitingPFELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 1, 2027Sponsor estimateNo phase registeredNCT06398626An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative ColitisPfizer · Colitis, UlcerativeActive, not recruitingPFELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 27, 2024ActualPhase 1NCT06273839A Study to Learn How Different Forms of Study Medicine Tafamidis Are Taken Up Into The Blood in Healthy AdultsPfizer · HealthyCompletedPFELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 7, 2024ActualPhase 1NCT06190561A Study to Learn How Different Products of the Study Medicine Called PF-07940367 Are Taken up Into the Blood in Healthy AdultsPfizer · HealthyCompletedPFELead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 25 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScannerShowing the first 25 trials. There are 5,910 more in this window; the full list is part of TrialScanner.
Unlock with TrialScanner